Clinical trial
A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
NCT01969799 is registered in ClinicalTrials.gov with Cardeas Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Blinded, Placebo-Controlled, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered Via the Investigational eFlow® Inline System in Mechanically Ventilated Patients With Gram-negative Bacterial Pneumonia (IASIS)
- Lead sponsor
- Cardeas Pharma
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2013
- Completion date
- April 30, 2016
- Enrollment
- 143 (actual)
- Sites
- 41
Conditions
As the registry lists them; a condition with its own page is linked.